[go: up one dir, main page]

BR9408613A - Purified form of streptogramins use of a cocrystallized compound process of preparation of purified form of streptogramins process of purification of a minor component of group a of streptogramins and pharmaceutical composition - Google Patents

Purified form of streptogramins use of a cocrystallized compound process of preparation of purified form of streptogramins process of purification of a minor component of group a of streptogramins and pharmaceutical composition

Info

Publication number
BR9408613A
BR9408613A BR9408613A BR9408613A BR9408613A BR 9408613 A BR9408613 A BR 9408613A BR 9408613 A BR9408613 A BR 9408613A BR 9408613 A BR9408613 A BR 9408613A BR 9408613 A BR9408613 A BR 9408613A
Authority
BR
Brazil
Prior art keywords
streptogramins
purified form
purification
preparation
pharmaceutical composition
Prior art date
Application number
BR9408613A
Other languages
Portuguese (pt)
Inventor
Pascal Anger
Bertrand Bonnavaud
Alain Gallet
Patrick Lefevre
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from APAP/P/1994/000660A external-priority patent/AP520A/en
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Priority claimed from CN94195158A external-priority patent/CN1159197A/en
Publication of BR9408613A publication Critical patent/BR9408613A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR9408613A 1993-02-17 1994-08-12 Purified form of streptogramins use of a cocrystallized compound process of preparation of purified form of streptogramins process of purification of a minor component of group a of streptogramins and pharmaceutical composition BR9408613A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9301787A FR2701709B1 (en) 1993-02-17 1993-02-17 Purified form of streptogramins, its preparation and the pharmaceutical compositions containing it.
APAP/P/1994/000660A AP520A (en) 1993-02-17 1994-08-01 Purified form of streptogramins, its preparation and pharmaceutical compositions containing it.
CN94195158A CN1159197A (en) 1993-02-17 1994-08-12 Purified form of streptavidin, its preparation and pharmaceutical composition containing it
PCT/FR1994/001006 WO1996005219A1 (en) 1993-02-17 1994-08-12 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it
OA60964A OA10400A (en) 1993-02-17 1997-02-07 Purified form of streptogramins its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
BR9408613A true BR9408613A (en) 1997-09-16

Family

ID=33437085

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9408613A BR9408613A (en) 1993-02-17 1994-08-12 Purified form of streptogramins use of a cocrystallized compound process of preparation of purified form of streptogramins process of purification of a minor component of group a of streptogramins and pharmaceutical composition

Country Status (21)

Country Link
JP (1) JPH06298664A (en)
AU (1) AU678785B2 (en)
BE (1) BE1006554A3 (en)
BR (1) BR9408613A (en)
CA (1) CA2115807A1 (en)
CZ (1) CZ285541B6 (en)
ES (1) ES2081763B1 (en)
FI (1) FI111009B (en)
FR (1) FR2701709B1 (en)
GB (1) GB2275269B (en)
GR (1) GR1002385B (en)
HU (1) HUT66821A (en)
IL (1) IL108641A (en)
IT (1) IT1269214B (en)
LU (1) LU88454A1 (en)
NO (1) NO940533D0 (en)
NZ (1) NZ250884A (en)
PL (1) PL174835B1 (en)
PT (1) PT101460B (en)
SK (1) SK18494A3 (en)
ZA (1) ZA941024B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723373B1 (en) 1994-08-02 1996-09-13 Rhone Poulenc Rorer Sa PURIFIED FORM OF STREPTOGRAMINS, ITS PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2775288B1 (en) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa STREPTOGRAMIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
FR2841563B1 (en) * 2002-06-28 2006-09-01 Aventis Pharma Sa NEW VARIANTS OF THE PAPP POLYPEPTIDE OF BACTERIA GENUS STREPTOMYCES
ITUB20169994A1 (en) * 2016-01-14 2017-07-14 Phf Sa New crystalline forms of immunomodulatory drugs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (en) * 1983-07-13 1985-10-25 Rhone Poulenc Sante NOVEL SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
FR2619008B1 (en) * 1987-08-03 1990-06-29 Cird USE OF SYNERGISTINS IN ANTI-ACNEIC PHARMACEUTICAL OR COSMETIC COMPOSITIONS
FR2674539B1 (en) * 1991-03-28 1993-05-21 Rhone Poulenc Rorer Sa PROCESS FOR THE ENZYMATIC PREPARATION OF MACROLACTONE.
FR2689518B1 (en) * 1992-04-01 1995-04-07 Rhone Poulenc Rorer Sa Microorganisms, preparation process and use.

Also Published As

Publication number Publication date
GB2275269A (en) 1994-08-24
PL302250A1 (en) 1994-08-22
GB9403057D0 (en) 1994-04-06
CZ285541B6 (en) 1999-09-15
IT1269214B (en) 1997-03-21
GR1002385B (en) 1996-07-03
IL108641A0 (en) 1994-05-30
PT101460B (en) 1999-11-30
HUT66821A (en) 1995-01-30
GB2275269B (en) 1997-07-09
LU88454A1 (en) 1994-12-01
HU9400447D0 (en) 1994-05-30
NZ250884A (en) 1995-12-21
IL108641A (en) 1998-12-27
FR2701709B1 (en) 1995-04-07
FI940717A0 (en) 1994-02-16
CA2115807A1 (en) 1994-08-18
FI111009B (en) 2003-05-15
JPH06298664A (en) 1994-10-25
ITMI940192A1 (en) 1995-08-03
AU678785B2 (en) 1997-06-12
FI940717A7 (en) 1994-08-18
ITMI940192A0 (en) 1994-02-03
AU5510094A (en) 1994-08-25
NO940533D0 (en) 1994-02-16
ZA941024B (en) 1994-08-25
PT101460A (en) 1994-09-30
PL174835B1 (en) 1998-09-30
NO940533L (en) 1994-08-18
CZ32694A3 (en) 1994-09-14
FR2701709A1 (en) 1994-08-26
ES2081763A1 (en) 1996-03-01
ES2081763B1 (en) 1997-01-16
BE1006554A3 (en) 1994-10-11
SK18494A3 (en) 1995-02-08
GR940100078A (en) 1994-10-31

Similar Documents

Publication Publication Date Title
BR9406128A (en) Use of a process compound for the treatment and / or prevention of psychotic disorders compound pharmaceutical composition processes for the preparation of a compound and a pharmaceutical composition
BR9503812A (en) Compound pharmaceutical composition use method of treatment of a human process for the preparation of a compound
PT98944A (en) PROCESS FOR THE PREPARATION OF ALTERED ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFECTIONS
BR9504791A (en) Polypeptide compound Process for preparing a polypeptide compound Pharmaceutical composition Medication and method for prophylactic and / or therapeutic treatment of infectious diseases
BR9407720A (en) Compound pharmaceutical composition and process for the prevention or treatment of immunoregulatory disorders or diseases that comprise the administration of the compound
BR1100850A (en) Compound, process for the preparation of a compound, and pharmaceutical composition
BR9702147A (en) Pharmaceutical composition use of a pharmaceutical composition and process for the treatment of pain associated with periodontal scarification and for the preparation of a pharmaceutical composition
FI941987A7 (en) Novel amino acid derivatives, processes for their preparation and pharmaceutical compositions containing these compounds
BR9508586A (en) Compounds of the same preparation process use the same process of treating a clinical condition in a mammal and pharmaceutical composition
EE9600019A (en) 2,8-Disubstituted quinazolinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
BR9707489A (en) Compound pharmaceutical composition and process to treat a patient suffering from a physiological disorder
BR9502471A (en) Guanidine compound Process for preparing a guanidine compound Pharmaceutical composition Use of a guanidine compound Method for the prophylactic or therapeutic treatment of diseases and process for preparing a pharmaceutical composition
BR9607346A (en) Compound use of a compound, pharmaceutical composition and process for the treatment of a mammal and for and preparation of compounds
BR9813319A (en) Compound, pharmaceutical composition for treating bacterial infections, and processes for treating bacterial infections and for preparing a compound
PT100000A (en) PROCESS OF PREPARATION OF TANACETUM PARTHENIUM EXTRACTS CONTAINING SESQUITERPEN-LACTONE EXTRACTS AND PHARMACEUTICAL COMPOSITIONS
FI943754L (en) Method for purifying perfluorocarbons and use of purified perfluorocarbons
BR1101176A (en) Purified form of streptogramins, use of a co-crystallized compound, process of preparing a purified form of streptogramin, purified component of group a of streptogramins, use of one or more minor components of group a of streptogramins, co-crystallized compounds and composition pharmaceutical
BR9408613A (en) Purified form of streptogramins use of a cocrystallized compound process of preparation of purified form of streptogramins process of purification of a minor component of group a of streptogramins and pharmaceutical composition
FI963440L (en) Novel amino acid derivatives, their preparation process and pharmaceutical compositions containing these compounds
BR9708864A (en) Compound pharmaceutical composition and process for the treatment or prevention of a bacterial infection in a mammalian patient
DE69419639D1 (en) Process for the preparation of fructose 2,6-diphosphate and purification process therefor
PT93980A (en) PROCESS OF ADMINISTRATION OF ACID HYDROCARBONS ACIDS WITHOUT USE OF CAUSTIC SUBSTANCES
ID21369A (en) PHARMACEUTICAL COMPOSITION FOR HEALING OF DISEASES CAUSED BY VIRUS
BR9505131A (en) Composition of polyols, preparation process and application thereof
BR9610851A (en) Compound compound preparation process medicine pharmaceutical composition and use of the compound

Legal Events

Date Code Title Description
FA Application withdrawn